Business

TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.

TAMPA, FL, Oct. 17, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange

articleScienture Holdings, Inc.October 17, 20235/company/scienture-holdings-inc/news/trxade-health-inc-affirms-its-commitment-to-the-pharmaceutical-space-via-its-subsidiary-trxade-inc-which-operates-the-pharmaceutical-marketplace-and-added-more-members-in-the-third-quarter-of-2023
TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.

About this update from Scienture Holdings, Inc.

[{"type":"text","content":"TAMPA, FL, Oct. 17, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (NASDAQ: MEDS) (“TRxADE”), a parent company of pharmaceutical business-to-business exchange platform, which recently merged with Superlatus, Inc. (“Superlatus”), today reconfirms its commitment to pharmaceutical marketplace via its subsidiary Trxade, Inc. and is pleased to clarify its commitment to the pharmaceutical industry. Trxade, Inc., a subsidiary of Trxade Health, Inc. (the “Company”), will continue to focus on the pharmaceutical space. The Company is dedicated to serving the pharmaceutical industry and its over 13,000 members, reinforcing its position as a key player in this critical sector, adding 199 new members to its marketplace in the third quarter of 2023. In recent weeks, there may have been some confusion regarding the Company’s strategic direction in the pharmaceutical space. We are pleased to clarify that this confusion was the result of a misunderstanding, and the Company's commitment to the pharmaceutical industry remains as strong as ever. The Company maintains its sole focus on the pharmaceutical sector, providing innovative solutions to address the evolving needs of this industry. The Company, under the leadership of its experienced and visionary team, continues to develop and deliver cutting-edge technologies, services, and solutions to empower pharmaceutical professionals, pharmacists, and healthcare stakeholders. The Company's dedication to advancing pharmaceutical care, increasing transparency, and improving accessibility to medications remains at the core of its mission. In light of the ongoing changes and challenges in the pharmaceutical industry, the Company remains committed to its mission of driving innovation, fostering partnerships, and contributing to the growth and success of its customers and partners. The Company's unwavering focus on the pharmaceutical sector enables it to better address the unique needs and challenges facing this vital industry. The Company would like to extend gratitude to its loyal customers, partners, and stakeholders for their continued support. We remain committed to providing exceptional service, fostering innovation, and supporting the growth and prosperity of the pharmaceutical space. About Trxade, Inc. Trxade, Inc. is a safe and secure platform for pharmacies to utilize in its day-to-day operations. ...

More updates from Scienture Holdings, Inc.